首页> 外文期刊>European journal of pharmaceutical sciences >Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers
【24h】

Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers

机译:齐多夫定负载唾液酸共轭甘露糖基化聚亚丙基亚胺树枝状聚合物的合成,表征和靶向潜力

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The present investigation was aimed at exploring dual targeting of anti-HIV drug, zidovudine (ZDV) via sialic acid conjugated-mannosylated poly(propyleneimine) (PPI) dendritic nano-constructs. Fourth generation PPI dendrimers, sialic acid conjugated PPI dendrimers (SPPI), mannose conjugated PPI dendrimers (MPPI) and dual ligand system i.e. sialic acid conjugated- mannosylated PPI dendrimers (SMPPI) were synthesized and characterized by FT-IR and 1H NMR spectroscopies and were further confirmed by size exclusion chromatography and differential scanning calorimetry. Various parameters like drug loading, pH dependent in vitro release, hemolytic toxicity, macrophage uptake and cytotoxicity concerning PPI, SPPI, MPPI and SMPPI dendrimers were evaluated. ZDV loaded SMPPI, SPPI and MPPI have shown reduced hemolytic toxicity, cytotoxicity and in vitro drug release at pH 7.4. Extremely significant (P0.001) increase in cellular uptake of ZDV by macrophage cells was observed in case of SMPPI as compared to PPI and free drug. The in vivo blood level and tissue distribution studies in albino rats also demonstrated potential of dual targeted system towards sialoadhesin and carbohydrate receptors. The drug concentration in lymph nodes was increased to about 28 times in case of SMPPI (1335 ?? 17.6 ng/g) as compared to free drug (48 ?? 5.8 ng/g) at 6th hr. The results suggested that such dual ligand dendritic system (SMPPI) hold potential to enhance biocompatibility and site specific delivery of antiretroviral drug, ZDV. ? 2013 Elsevier B.V. All rights reserved.
机译:本研究旨在通过唾液酸共轭-甘露糖基化的聚(丙烯亚胺)(PPI)树突状纳米结构探索抗艾滋病毒药物齐多夫定(ZDV)的双重目标。合成了第四代PPI树枝状大分子,唾液酸共轭PPI树枝状大分子(SPPI),甘露糖共轭PPI树枝状大分子(MPPI)和双配体体系,即唾液酸共轭-甘露糖基化的PPI树枝状大分子(SMPPI),并通过FT-IR和1H NMR光谱进行了表征。通过尺寸排阻色谱法和差示扫描量热法进一步证实。评估了各种参数,例如载药量,pH依赖的体外释放,溶血毒性,巨噬细胞摄取和有关PPI,SPPI,MPPI和SMPPI树状聚合物的细胞毒性。 ZDV装载的SMPPI,SPPI和MPPI在pH 7.4时显示出降低的溶血毒性,细胞毒性和体外药物释放。与PPI和游离药物相比,在SMPPI的情况下,巨噬细胞对ZDV的细胞摄取极为显着(P <0.001)。在白化病大鼠中的体内血液水平和组织分布研究还证明了针对唾液酸粘附素和碳水化合物受体的双重靶向系统的潜力。在第6小时,SMPPI(1335≤17.6 ng / g)的情况下,淋巴结中的药物浓度比游离药物(48≤5.8 ng / g)的约28倍。结果表明,这种双配体树突状系统(SMPPI)具有增强抗逆转录病毒药物ZDV的生物相容性和位点特异性递送的潜力。 ? 2013 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号